dean g. tang laboratory
M.D. Anderson Cancer Center
Science-Park Research Division
Post-Doc Association
Graduate School Program
all about us   research publications protocols meetings lab outings contact us home

 

 

Invited Review Articles

1.   Tang DG, Tian HS.  Anti-cancer effect of NSAID indomethacin.  Oncology 5:273-277, 1989.

2.   Tang DG, Tian HS.  The anti-tumor and anti-metastatic effect of indomethacin:  Exploration of its mechanisms of action.  J. Pharmcol. Biochem. Agents 11:151-153, 1990.

3.   Tang DG, Tian HS.  Anti-metastatic effect of prostacyclin (PGI2): Experimental and clinical evidence.  J. Toxicol. Pharmacol.  2:83-86, 1990.

4.   Honn KV, Tang DG, Chen Y.  Platelets and cancer metastasis: More than an epiphenomenon.  Seminar Thromb. Hemost. 18:390-413, 1992.

5.   Chen Y, Liu B, Tang DG, Honn KV.  Fatty acid modulation of tumor cell-platelet-vessel wall interaction.  Cancer Metastasis Rev. 11:389-410, 1992.

6.   Honn KV, Tang DG.  Hemostasis and metastasis: An overview.  Cancer Metastasis Rev. 11:223-226, 1992.

7.   Honn KV, Tang DG, Crissman JD.  Platelets and cancer metastasis: A causal relationship?  Cancer Metastasis Rev. 11:325-351, 1992.

8.   Honn KV, Tang DG.  Adhesion molecules and cancer cell interaction with endothelium and subendothelial matrix.  Cancer Metastasis Rev. 11:353-375, 1992.

9.   Honn KV, Tang DG.  Commentary: Invasion and metastasis: New approaches to an old problem-The Kohn and Liotta Article Reviewed.  Oncology 7:61-62, 1993.

10.Tang DG, Honn KV.  12-Lipoxygenase, 12(S)-HETE, and cancer metastasis.  Annals N.Y. Acad. Sci. 722:199-215, 1994.

11.Honn KV, Tang DG, Gao X, Butovich I, Liu B, Timar J, Hagmann W.  12-Lipoxygenase and 12(S)-HETE: Role in cancer metastasis.  Cancer Metastasis Rev. 13:365-396, 1994.

12.Schneider MR, Tang DG, Honn KV.  Prostacyclin and its analogues: Antimetastatic effects and mechanisms of action.  Cancer Metastasis Rev. 13:349-364, 1994.

13.Tang DG, Honn KV.  Adhesion molecules and tumor metastasis: An update.  Invasion Metastasis 14:109-222, 1995.

14.Tang DG, Honn KV.  Adhesion molecules and tumor cell - vasculature interactions: Modulation by bioactive lipid molecules.  Curr. Topics Microbiol. Immunol. 213 (pt 2):69-88, 1996.

15.Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I, Redman B, Sakr W, Severson R, Tang DG, Wood DP, Jr.  Prostate Cancer: Old Problems and New Approaches. Part I: Epidemiology, incidence and genetic alterations.  Pathol. Oncol. Res. 2:98-109, 1996.

16.Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I, Redman B, Sakr W, Severson R, Tang DG, Wood DP, Jr.  Prostate Cancer: Old Problems and New Approaches. Part II: Diagnostic and prognostic markers, pathology, and biological aspects.  Pathol. Oncol. Res. 2:191-211, 1996.

17.Tang DG, Porter AT.  Apoptosis: A current molecular analysis.  Pathol. Oncol. Res. 2:117-137, 1996.

18.Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes JE, Powell I, Redman B, Sakr W, Severson R, Tang DG, Wood DP, Jr.  Prostate Cancer: Old Problems and New Approaches. Part III: Prevention and treatment.  Pathol. Oncol. Res. 2:276-292, 1997.

19.Tang DG, Porter AT.  Target to apoptosis: A hopeful weapon for prostate cancer.  Prostate 32:284-293, 1997.

20.Tang DG, La E, Kern J, Kehrer JP.  Fatty acid oxidation and signaling in apoptosis.  Biol. Chem. 383:425-442, 2002.

21.Tang DG, Conti C. Endothelial cell development, vasculogenesis, angiogenesis and tumor neovascularization: an update. Semin. Thromb. Hemostasis. 30:109-117, 2004.

Book chapters:

1.   Tang DG, Diglio CA, Honn KV.  12(S)-HETE-induced microvascular endothelial cell retraction is mediated by cytoskeletal rearrangement dependent on PKC activation.  In: Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. (Nigam S, Honn KV, Marnett LJ, Walden TL, eds), Kluwer Academic Publishers, Boston, pp 219-229, 1992.

2.   Taylor JD, Timar J, Tang DG, Bazaz R, Chopra H, Kimler V, Honn KV.  12(S)-HETE induces cytoskeletal phosphorylations and rearrangement in melanoma cells.  In: Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury.  (Nigam S, Honn KV, Marnett LJ, Walden TL, eds), Kluwer Academic Publishers, Boston, pp 635-638, 1992.

3.   Honn KV, Tang DG, Chen Y.  Adhesion molecules and site-specific metastasis.  In: Thrombosis: An Update.  (Neri Serneri SS, Gensini GF, Abbate R, Prisco D, eds) Scientific Press, Florence, pp 269-303, 1992.

4.   Tang DG, Honn KV.  Eicosanoids and tumor cell metastasis.  In: Prostaglandin Inhibitors in Tumor Immunology and Immunotherapy.  (Harris JE, Braun DP, Anderson KM, eds), CRC press, pp 73-108, 1994.

5.   Honn KV, Chen YQ, Tang DG.  Interactions among platelets, tumor cells and the vessel wall.  In: Principles of Cell Adhesion.  (Steiner M, Richardson PD, eds), CRC press, Boca Raton, pp 317-335, 1994.

6.   Tang DG, Honn KV, Taylor JD, Porter AT.  Dual regulatory role of cyclooxygenase and lipoxygenase and their products in cell survival and apoptosis.  In: Frontiers in Bioactive Lipids- 96.  (J.Y. Vanderhoek, ed.).  Plenum Press, pp 133-139, 1996.

7.   Honn KV, Tang DG.  Eicosanoid 12(S)-HETE upregulates endothelial cell avb3 integrin expression and promotes tumor cell adhesion to vascular endothelium.  Adv. Exp. Med. Biol. 400:766-774, 1997.

8.   Tang DG, Honn KV.  Role of protein kinase C and phosphatase in 12(S)-HETE-induced tumor cell cytoskeletal reorganization.  Adv. Exp. Med. Biol. 400:349-361, 1997.

9.   Timar J, Bazaz R, Tang DG, Kimler V, Taylor JD, Honn KV.  Post-translational regulation of surface integrin expression in tumor cells by 12-(S)-HETE.  Adv. Exp. Med. Biol. 400:757-763, 1997.

10.Tang DG, Porter AT, Honn KV.  Critical Role of Arachidonate Lipoxygenases in Regulating Apoptosis.  Adv. Exp. Med. Biol. 407:405-411, 1997.

11.Raff M, Apperly J, Kondo T, Tokumoto Y, Tang DG.  Timing cell-cycle exit and differentiation in oligodendrocyte development.  Novartis Found. Symp. 237:100-107, 2001.

12.Choy G, Liu J-W, Chandra D, and Tang DG.  Cell survival signaling during apoptosis: Implications in drug resistance and anti-cancer therapeutic development.  In: Advances in Targeted Approaches for Cancer Therapy.  (Schultz RM, ed).  In press, 2005.

13.Tang DG, and Kehrer JP.  Carcinogenesis – Balance between apoptosis survival pathways.  In: Apoptosis, Cell Signaling, and Human Diseases: Molecular Mechanisms.  (Srivastava, R, ed). Humana Press.  In press, 2005.